Antiphospholipid antibodies and antiphospholipid syndrome in patients with malignancies: features, incidence, identification, and treatment.

@article{Miesbach2008AntiphospholipidAA,
  title={Antiphospholipid antibodies and antiphospholipid syndrome in patients with malignancies: features, incidence, identification, and treatment.},
  author={Wolfgang Miesbach},
  journal={Seminars in thrombosis and hemostasis},
  year={2008},
  volume={34 3},
  pages={282-5}
}
Thrombotic events associated with antiphospholipid (aPL) antibodies can be the first manifestation of malignancy. The pathologic significance of aPL antibodies in patients with malignancies, however, is still unclear. It remains an unresolved issue as to whether the presence of aPL antibodies may be considered as an "epiphenomenon" of the malignancy itself or whether it contributes directly to the development of thrombosis in these patients. In particular, solid tumors may be associated with… CONTINUE READING

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…